CytomX Therapeutics, Inc. Annual Return On Assets in % from 2016 to 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
CytomX Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2016 to 2024.
  • CytomX Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2025 was 36 %, a 523% increase year-over-year.
  • CytomX Therapeutics, Inc. annual Return On Assets for 2024 was 21.1 %.
  • CytomX Therapeutics, Inc. annual Return On Assets for 2023 was -0.26 %, a 99.3% increase from 2022.
  • CytomX Therapeutics, Inc. annual Return On Assets for 2022 was -38 %, a 27% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 21.1 +21.4 Jan 1, 2024 Dec 31, 2024
2023 -0.26 +37.8 +99.3% Jan 1, 2023 Dec 31, 2023
2022 -38 -8.09 -27% Jan 1, 2022 Dec 31, 2022
2021 -30 -13.5 -81.7% Jan 1, 2021 Dec 31, 2021
2020 -16.5 +17.5 +51.5% Jan 1, 2020 Dec 31, 2020
2019 -34 -14 -70% Jan 1, 2019 Dec 31, 2019
2018 -20 -6.87 -52.4% Jan 1, 2018 Dec 31, 2018
2017 -13.1 +16.7 +56% Jan 1, 2017 Dec 31, 2017
2016 -29.8 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.